Skip to content

AeroEclipse ONE BAN

by Trudell Medical International

510(k) K200063

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Abbreviated NumberK200063 Date17 Jul 2020ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
13 Jan 2020
FDA decision
17 Jul 2020 (Substantially Equivalent)
FDA review time
186 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K200063 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K200063 decided 17 Jul 2020 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
CAF
Device class
Class II
Regulation
21 CFR Part 868.5630
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The AeroEclipse ONE BAN is a nebulizer designed for direct patient interface, classified under product code CAF. It delivers aerosolized medication to patients via inhalation, facilitating respiratory therapy for conditions requiring precise medication administration.

This device is intended for single-use and is supplied sterile. It operates in clinical settings such as anesthesia and respiratory care, with regulatory authorizations including FDA 510(k) clearance and MDR compliance. The device is reusable only after proper cleaning and sterilization, adhering to manufacturer guidelines for reprocessing.

Similar devices

Other devices filed under FDA product code CAF (Nebulizer (Direct Patient Interface)).

Other devices from Trudell Medical International

See all devices from Trudell Medical International →